Kiniksa Pharmaceuticals International, plc ( KNSA) - Stock Earnings
KNSA Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Oct. 27, 2026 BeforeMarket | — / — | — | — / — | — |
KNSA Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | 14.2 million USD | 202.1 million USD |
| 2026Q1 | 22.6 million USD | 214.3 million USD |
| 2026Q2 | 25.4 million USD | 243.6 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
KNSA Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 14.1 million USD | 270.3 million USD |
| 2024 | -43.2 million USD | 423.2 million USD |
| 2025 | 59.0 million USD | 677.6 million USD |
| 2026 Est. | — | — |
KNSA
Price: $79.48
Earnings Per Share: 0.99 USD
P/E Ratio: 74.15
Exchange: NMS
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: Bermuda
Volume: 221500
Market Capitalization: 5.9 billion